Implications of androgen assay accuracy in the phenotyping of women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 2, 2016, Pages 610-618

  Tosi, Flavia ^a   Fiers, Tom ^b   Kaufman, Jean Marc ^b   Dall'Alda, Marlene ^a   Moretta, Rossella ^a   Giagulli, Vito Angelo ^c   Bonora, Enzo ^a   Moghetti, Paolo ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c ASL Bari   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; TESTOSTERONE;

ADULT; ANDROGEN ASSAY; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CAUCASIAN; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EQUILIBRIUM DIALYSIS; FEMALE; GOLD STANDARD; HIGH RISK POPULATION; HORMONE DETERMINATION; HUMAN; HYPERANDROGENISM; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TESTOSTERONE BLOOD LEVEL; ALGORITHM; BLOOD; COMPLICATION; DIALYSIS; LABORATORY DIAGNOSIS; REPRODUCIBILITY; STANDARD; YOUNG ADULT;

ADULT; ALGORITHMS; ANDROGENS; ANDROSTENEDIONE; DIALYSIS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; HYPERANDROGENISM; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TESTOSTERONE; YOUNG ADULT;

EID: 84959376958     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-2807     Document Type: Article

References (29)

1. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: toward a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic Ovary Syndrome. Cambridge MA: Blackwell Scientific Publications; 1992:377-384.
2. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS). The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Hum Reprod. 2004;19:41-47.
3. Azziz R, Carmina E, Dewailly D, et al. Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456-488.
4. Legro RS, Arslanian SA, Ehrmann DA, et al. Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endodoicrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98:4565-4592.
5. Moghetti P, Tosi F, Bonin C, et al. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98:E628-E637.
6. Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril. 2005;83:1717-1723.
7. Escobar-Morreale HF, Carmina E, Dewailly D, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2012;18:146-170.
8. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab. 2007;92:405-413.
9. Taieb J, Mathian B, Millot F, et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem. 2003;49:1381-1395.
10. Miller KK, Rosner W, Lee H, et al. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab. 2004;89:525-533.
11. Wang C, Catlin DH, Demers LM, Starcevic B, Swerdloff RS. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab. 2004;89:534-543.
12. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666-3672.
13. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-1645.
14. Gray DS, Bray GA, Gemayel N, Kaplan K. Effect of obesity on bioelectrical impedance. Am J Clin Nutr. 1989;50:255-260.
15. Vermeulen A, Stoica T, Verdonck L. The apparent free testosterone concentration, an index of androgenicity. J Clin Endocrinol. 1971; 33:759-767.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
17. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
18. DeFronzo RA. The triumvirate: α-Cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988;37:667-687.
19. Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens. 1988;16:895-906.
20. Nahoul K, Dehennin L, Scholler R. Radioimmunoassay of plasma progesterone after oral administration of micronized progesterone. J Steroid Biochem. 1987;26:241-249.
21. Bell A, Meek CL, Viljoen A. Evidence of biochemical hyperandrogenism in women: the limitations of serum testosterone quantitation. J Obstet Gynaecol. 2012;32:367-371.
22. Legro RS, Schlaff WD, Diamond MP, et al. Reproductive Medicine Network. Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab. 2010;95:5305-5313.
23. Janse F, Eijkemans MJ, Goverde AJ, et al. Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results. Eur J Endocrinol. 2011;165:925-933.
24. SalamehWA,Redor-GoldmanMM,Clarke NJ, Mathur R, Azziz R, Reitz RE. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria. Fertil Steril. 2014;101:1135-1141.
25. Gallagher LM, Owen LJ, Keevil BG. Simultaneous determination of androstenedione and testosterone in human serum by liquid chromatography-tandem mass spectrometry. Ann Clin Biochem. 2007; 44:48-56.
26. Bruce SJ, Rey F, Béguin A, Berthod C, Werner D, Henry H. Discrepancy between radioimmunoassay and high performance liquid chromatography tandem-mass spectrometry for the analysis of androstenedione. Anal Biochem. 2014;455:20-25.
27. Keefe CC, Goldman MM, Zhang K, Clarke N, Reitz RE, Welt CK. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry. PLoS One. 2014;9: e93805.
28. Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored Third PCOS Consensus Workshop Group. Fertil Steril. 2012;97:28-38.
29. O'Reilly MW, Taylor AE, Crabtree NJ, et al. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. J Clin Endocrinol Metab. 2014;99: 1027-1036.